Covaxin trials on kids completed
Bharat Biotech has completed the Phase II/III clinical trials of Covaxin on children in the 2-18 years age group and is all set to submit the data to the Drugs Controller General of India (DCGI), the company’s chairman & managing director Dr Krishna Ella said on Tuesday.
Admin
0
6
Bharat Biotech has completed the Phase II/III clinical trials of Covaxin on children in the 2-18 years age group and is all set to submit the data to the Drugs Controller General of India (DCGI), the company’s chairman & managing director Dr Krishna Ella said on Tuesday. 
